Drug Profile
Sevelamer hydrochloride - Sanofi
Alternative Names: TasermityLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Genzyme Europe
- Developer Sanofi
- Class Antihyperglycaemics; Chlorinated hydrocarbons; Epoxy compounds; Hyperphosphataemia therapies; Polyamines; Small molecules
- Mechanism of Action Chelating agents; Phosphate binding protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Hyperphosphataemia